Tim Van Hauwermeiren
Board Member
Lexeo Therapeutics, Inc. (LXEO)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tim Van Hauwermeiren
Tim Van Hauwermeiren is recorded as Board Member at Lexeo Therapeutics, Inc. (LXEO). Lexeo Therapeutics, Inc. reported in an 8-K filed July 8, 2024 that Tim Van Hauwermeiren was appointed director, effective July 5, 2024.
“On July 5, 2024 (the "Appointment Date"), Tim Van Hauwermeiren was appointed to the board of directors (the "Board") of Lexeo Therapeutics, Inc. (the "Company").”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lexeo Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- R. Nolan Townsend CEO, Board Member
- Kyle Rasbach CFO, Chief Accounting Officer
- Louis Tamayo CFO
- Jose Manuel Otero COO
- Jose Manuel Otero, Ph.D. COO
- Brenda Cooperstone Board Member
- Continuing Directors Board Member
- Dr. Laura Sepp-Lorenzino Board Member
- Laura Sepp-Lorenzino Board Member
- Mette Kirstine Agger Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.